(lp0
S"BioDelivery Sciences to Host Conference Call and Webcast Reporting Fourth ... PR Newswire  - Mar 9, 2017 RALEIGH, N.C., March 9, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  announced that it will report its fourth quarter and full-year 2016 financial results and host a conference call and webcast at 8:00 AM Eastern Time on&nbsp;...Roth Capital Analysts Give BioDelivery Sciences International, Inc.  a ... - The Cerbat GemBioDelivery Sciences International, Inc.'s  stock price is Worth at $2 ... - Hot Stocks Point"
p1
aS"Why Shares in BioDelivery Sciences International, Inc. Are Tumbling Motley Fool - Jun 1, 2015 So What: It shouldn't be too surprising to learn that a clinical stage company like BioDelivery Sciences International has had to raise money to help usher along drugs in its research program. According to the Tufts Center for the Study of Drug ...BioDelivery Sciences Lands $20M to Prep for Drug Launch - XconomyBioDelivery Sciences Adds $20 Million in Debt Financing from MidCap Financial - PR Newswire "
p2
aS'BioDelivery Sciences Announces the Hiring of Peter Ginsberg as Vice President ... PR Newswire  - Dec 14, 2016 RALEIGH, N.C., Dec. 14, 2016 /PRNewswire/ -- BioDelivery Sciences International, Inc.  announced that Peter Ginsberg has joined the company as Vice President of Business Development.Company Update : Why BioDelivery Sciences International, Inc ... - Smarter AnalystOn heels of Belbuca reacquisition, BDSI makes business development hire - Triangle Business Journal'
p3
aS'BioDelivery Sciences International, Inc.  to Release Earnings on Friday Chaffey Breeze - Mar 15, 2017 BioDelivery Sciences International logo BioDelivery Sciences International, Inc.  is scheduled to release its earnings data before the market opens on Friday, March 17th.BioDelivery Sciences International Inc. - Receive News &amp; Ratings Daily - BBNSBioDelivery Sciences International, Inc.  Stock Rating Lowered by Zacks ... - The Cerbat Gem'
p4
aS'BioDelivery Sciences Reacquires License to BELBUCA from Endo Pharmaceuticals PR Newswire  - Dec 8, 2016 RALEIGH, N.C., Dec. 8, 2016 /PRNewswire/ --BioDelivery Sciences International, Inc.  announced that it has entered into an agreement with Endo Pharmaceuticals, Inc.  terminating their licensing of rights for BELBUCA&nbsp;...BioDelivery Regains Belbuca Opioid Rights  - InvestopediaEndo Sells Back Rights for Opioid Painkiller - Wall Street Journal'
p5
aS'MonoSol Rx Files Patent Infringement Suit against BioDelivery Sciences ... GlobeNewswire  - Jan 13, 2017 ... a specialty pharmaceutical company utilizing its PharmFilm drug delivery technology to improve patient outcomes and to address unmet needs, today filed a patent infringement case against BioDelivery Sciences International, Inc. (Nasdaq:BDSI ...'
p6
aS'BioDelivery Sciences International, Inc.  Shares Open Higher on Back of ... Smarter Analyst - Sep 23, 2016 BioDelivery Sciences International, Inc.  shares are up 13% this morning, after Janney Montgomery analyst Ken Trbovich upgraded BDSI from a Neutral to a Buy rating with a price target of $4, which implies an upside of 63% from current&nbsp;...Janney Montgomery Scott Upgrades BioDelivery Sciences International  to Buy - StreetInsider.com'
p7
aS'BioDelivery Sciences to Present at the 29th Annual ROTH Conference Yahoo Finance - Mar 8, 2017 RALEIGH, N.C., March 8, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  announced that Dr. Mark A. Sirgo, President and Chief Executive Officer, will present at the 29th Annual ROTH Conference. The presentation, which will be&nbsp;...Biodelivery Sciences International Inc  Files Form 4 Insider Selling ... - Energy IndexAnalysts See $-0.27 EPS for BioDelivery Sciences International, Inc. , 4 ... - Wolcott Daily'
p8
aS"Can BioDelivery Succeed With Belbuca? Seeking Alpha - Feb 10, 2017 BioDelivery  gave a pretty good presentation about Belbuca and the company's sales and marketing strategy going forward."
p9
aS"BioDelivery Sciences and Collegium Pharmaceutical Announce the Signing of a ... PR Newswire  - May 11, 2016 RALEIGH, N.C., May 11, 2016 /PRNewswire/ -- BioDelivery Sciences International, Inc.  and Collegium Pharmaceutical, Inc.  today announced the signing of a licensing agreement under which BDSI is granting the exclusive&nbsp;...Biodelivery Shareholders Should Be Disappointed With Collegium Deal - Seeking AlphaSluggish painkiller sales still hurting Raleigh's BioDelivery Sciences - Triangle Business Journal"
p10
a.